{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:23:27Z","timestamp":1788985407394,"version":"build-2803163510"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,31]]},"DOI":"10.7759\/cureus.81539","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T02:41:59Z","timestamp":1743475319000},"source":"Crossref","is-referenced-by-count":5,"title":["Oral Deucravacitinib for Treatment-Refractory Cutaneous Lupus Erythematosus"],"prefix":"10.7759","author":[{"given":"Ethan J","family":"Matthew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kritin K","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Paulger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Lupus erythematosus","author":"Lee LA","year":"2018","unstructured":"Lee LA, Werth VP. Lupus erythematosus. Dermatology. 4th edition. Bolognia JL, Schaffer JV, Cerroni L (ed): Elsevier, Poland; 2018. 1:662-80."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/art.42391","article-title":"Deucravacitinib, a tyrosine kinase 2 inhibitor, in systemic lupus erythematosus: a phase II, randomized, double-blind, placebo-controlled trial","volume":"75","author":"Morand E","year":"2023","unstructured":"Morand E, Pike M, Merrill JT, et al.. Deucravacitinib, a tyrosine kinase 2 inhibitor, in systemic lupus erythematosus: a phase II, randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 2023, 75:242-52. 10.1002\/art.42391","journal-title":"Arthritis Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19667","article-title":"Rapid clinical improvement of refractory subacute cutaneous lupus erythematosus with oral tyrosine kinase 2 inhibitor deucravacitinib: a case report","volume":"38","author":"Kurz B","year":"2024","unstructured":"Kurz B, Ivanova I, Drexler K, Berneburg M, G\u00fcnther F, Niebel D. Rapid clinical improvement of refractory subacute cutaneous lupus erythematosus with oral tyrosine kinase 2 inhibitor deucravacitinib: a case report. J Eur Acad Dermatol Venereol. 2024, 38:e434-6. 10.1111\/jdv.19667","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2024.04.032","article-title":"Discoid lupus erythematosus successfully treated with deucravacitinib","volume":"49","author":"Ezeh N","year":"2024","unstructured":"Ezeh N, Vleugels RA, Shahriari N. Discoid lupus erythematosus successfully treated with deucravacitinib. JAAD Case Rep. 2024, 49:59-61. 10.1016\/j.jdcr.2024.04.032","journal-title":"JAAD Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2023.07.030","article-title":"Successful treatment of refractory subacute cutaneous lupus erythematosus with deucravacitinib","volume":"39","author":"Bouch\u00e9 N","year":"2023","unstructured":"Bouch\u00e9 N, Al-Saedy MA, Song EJ. Successful treatment of refractory subacute cutaneous lupus erythematosus with deucravacitinib. JAAD Case Rep. 2023, 39:93-5. 10.1016\/j.jdcr.2023.07.030","journal-title":"JAAD Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/347588-oral-deucravacitinib-for-treatment-refractory-cutaneous-lupus-erythematosus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T02:42:01Z","timestamp":1743475321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/347588-oral-deucravacitinib-for-treatment-refractory-cutaneous-lupus-erythematosus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.81539","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,31]]}}}